📈 Live Market Tracking
Every NSE and BSE corporate filing, read and explained by AI within minutes — impact, key figures, short/long-term view and what to watch.
Live · AI analyzer runs every 5 min (07:00–23:55 IST)
Latest filing: 2026-09-25 15:54
161 analysed today
FollowTelegram
161
Today
149,562
All-time analysed
42,894
Positive
6,654
Negative
91,341
Neutral
8,605
Watch
📊 Last 7 days — analysed filings by sentiment
Note: These are AI-generated, educational summaries of public NSE
filings — grounded in each document, but not investment advice and possibly incomplete.
Verify against the original filing and consult a SEBI-registered adviser before acting.
11 announcements match the current filters (relevance ≥ 5).
Aarti Surfactants Faces Customs Penalty & Duty Demands Exceeding ₹3.3 Cr
Aarti Surfactants received an adverse order from the Commissioner of Customs (JNCH) concerning misclassification of imported goods. The order confirms differential duty demands totalling approximately ₹1.54 Cr (against which ₹2.25 Cr is already appropriated) and imposes a company penalty of ₹1.54 Cr, a ₹25 lakh redemption fine, and ₹20 lakh in personal penalties on the CEO & MD. The order also directs enforcement of a ₹2.76 Cr bond and ₹35 lakh bank guarantee. The company plans to contest the ruling by filing an appeal before the CESTAT.
Confidence: HIGH
What changedCustoms authorities rejected the declared classification of imported goods, reclassified them under CTH 34021200, and imposed duties, fines, and penalties.
Why it mattersThe immediate aggregate cash/financial exposure of ~₹3.5 Cr is modest relative to TTM revenue of ₹916 Cr (~0.4%), but personal penalties on the CEO and bank guarantee encashments present operational and governance scrutiny.
Differential duty demanded: Rs. 1,53,97,404Company penalty under Sec 114A: Rs. 1,53,97,404Pre-appropriated amount: Rs. 2,25,31,731Bond enforcement amount: Rs. 2,76,35,214Penalty on CEO & MD: Rs. 20,00,000
📅 Short termNegative sentiment overhang due to regulatory penalties and potential bank guarantee encashment, though financial impact is contained.
📈 Long termLimited, assuming future import consignments correctly adjust to the tariff classification or CESTAT grants relief.
⚠ Risk flags
- Litigation risk before CESTAT
- Cash outflow risk via enforcement of ₹2.76 Cr bond and ₹35 lakh bank guarantee
- Regulatory scrutiny extending to executive leadership
Key Highlights
Confirmed differential duty demands of ₹11,10,373 and ₹1,42,87,031 under Section 28(4) of the Customs Act, 1962
Penalty of ₹1,53,97,404 imposed on the company under Section 114A, plus ₹20,000,00 in total penalties on the CEO & MD
Company already appropriated ₹2,25,31,731 towards differential duty and interest liabilities
Confiscated 171.444 MTs of goods valued at ₹2,30,34,882 with an option of redemption fine of ₹25,00,000
Directed enforcement of a ₹2,76,35,214 bond and ₹35,00,000 bank guarantee issued by Axis Bank
👀 What to Watch
Track the filing of the appeal before the CESTAT and watch for any interim stay or relief regarding the encashment of bank guarantees and bond enforcement.
Aarti Surfactants Sets Sep 22, 2026 Record Date for Re 1/Share Final Dividend
Aarti Surfactants has fixed Tuesday, September 22, 2026, as the record date for determining shareholder eligibility for its final dividend of Re 1 per equity share (10% on face value of Rs 10) for FY 2025-2026. The dividend is subject to approval at the upcoming Annual General Meeting on September 29, 2026. Upon approval, payment will be completed on or before October 27, 2026.
Confidence: HIGH
What changedFormal fixation of the record date and AGM timeline for the previously recommended FY26 final dividend.
Why it mattersConfirms the timeline for cash distribution to shareholders following FY26 earnings.
Final Dividend per Share: Re 1.00Face Value: Rs 10Record Date: September 22, 2026AGM Date: September 29, 2026Payment Cut-off Date: October 27, 2026
📅 Short termStock will trade ex-dividend around September 22, 2026.
📈 Long termLimited; routine corporate action following annual financial closing.
Key Highlights
Final dividend recommended at 10% (Re 1 per equity share of face value Rs 10)
Record date fixed as Tuesday, September 22, 2026
Shareholder approval scheduled for AGM on Tuesday, September 29, 2026
Disbursement to be completed on or before Tuesday, October 27, 2026
👀 What to Watch
Track the AGM outcome on September 29, 2026, and ensure shareholding is in place before September 22, 2026 to be eligible for payout.
AARTISURF Credit Rating Upgraded to 'CRISIL A-/Stable' for Rs 200 Cr Bank Facilities
Aarti Surfactants Limited has transitioned its credit rating agency from CARE Ratings to CRISIL Ratings Limited. CRISIL has upgraded the company's long-term bank loan facilities rating to 'CRISIL A-/Stable' from 'CARE BBB+; Stable'. The revised rating covers total bank loan facilities of Rs 200 Crore, reflecting improved credit profile and financial stability.
Confidence: HIGH
What changedCredit rating upgraded to 'CRISIL A-/Stable' from 'CARE BBB+; Stable' across Rs 200 Crore bank facilities following a transition to CRISIL Ratings.
Why it mattersThe upgrade from BBB+ to A- category improves creditworthiness, potentially enabling cheaper debt financing for ongoing capex (such as the Rs 85 Cr expansion) and operational working capital.
Total bank facilities rated: Rs 200 CroreNew credit rating: CRISIL A-/StablePrevious credit rating: CARE BBB+; StableRated facilities vs TTM revenue: ~21.8%
📅 Short termPositive sentiment driver as an upgrade into the A- rating tier validates improving operational health and balance sheet management.
📈 Long termLowers cost of capital and strengthens relationships with lenders as the company scales its specialty surfactant manufacturing capacity.
⚠ Risk flags
- Proposed facility of Rs 10.5 Crore requires revalidation if not availed within 180 days.
Key Highlights
Long-term bank loan facilities rating upgraded to 'CRISIL A-/Stable' from 'CARE BBB+; Stable'
Total bank loan facilities rated stand at Rs 200 Crore
Rated facilities include Rs 125 Crore fund-based limits, Rs 64.5 Crore term loan from HSBC, and Rs 10.5 Crore proposed facilities
Agency transitioned from CARE Ratings Limited to CRISIL Ratings Limited on September 3, 2026
👀 What to Watch
Track whether the credit rating upgrade translates into lower borrowing costs or reduced interest spreads on existing and upcoming debt lines.
206% YoY PAT Growth: Aarti Surfactants Reports Strong Q1 FY27 Results with Margin Expansion
Aarti Surfactants reported a robust Q1 FY27 with consolidated revenue growing 26.4% YoY to ₹272.87 cr. Net profit surged 206% YoY to ₹9.00 cr, driven by significant margin expansion as operating margins improved from 5.39% to 7.48%. The company's inventory turnover also improved to 1.89 from 1.36, suggesting better operational efficiency. This performance is notable given the company's small market cap of ₹339 cr and its ongoing ₹85 cr capacity expansion program.
Confidence: HIGH
What changedThe company has demonstrated a sharp recovery in profitability and margins in Q1 FY27 after a period of margin suppression in FY25 and FY26.
Why it mattersThe margin expansion to 7.48% (up from a TTM average of 5.5%) suggests successful price hikes or a shift toward higher-margin specialty surfactants, which is vital for a company with a high debt-to-equity ratio of 0.50.
Revenue (Q1 FY27): ₹272.87 crNet Profit (Q1 FY27): ₹9.00 crOperating Margin: 7.48%Revenue vs TTM Revenue: 31.7%YoY PAT Growth: 206%
📅 Short termThe stock is likely to react positively in the short term due to the significant bottom-line beat and improved operational ratios.
📈 Long termLong-term value creation depends on the successful utilization of the new ₹85 cr capacity and the ability to maintain MNC client relationships in the competitive FMCG surfactant space.
⚠ Risk flags
- Raw material price volatility (fatty alcohols)
- High concentration in FMCG sector
- Execution risk of ongoing ₹85 cr capex
Key Highlights
Consolidated Revenue increased 26.4% YoY to ₹272.87 cr from ₹215.90 cr
Consolidated Net Profit jumped 206% to ₹9.00 cr compared to ₹2.94 cr in the year-ago quarter
Operating Margin expanded by 209 basis points YoY to 7.48%
Inventory Turnover Ratio improved significantly to 1.89 from 1.36 YoY
Interest Service Coverage Ratio improved to 5.80 from 3.55 YoY, indicating better debt servicing ability
👀 What to Watch
Monitor the execution timeline of the ₹85 cr capacity expansion at Pithampur and Silvassa, which is critical for sustaining the 15-20% growth target. Investors should also track raw material price trends (fatty alcohols) to see if the current 7.48% margin is sustainable.
₹18.15 Cr Redemption of 10.82 Lakh Preference Shares Approved by Aarti Surfactants
Aarti Surfactants has approved the redemption of 10,82,387 Non-Convertible Redeemable Preference Shares (NCRPS). The redemption is priced at ₹167.70 per share (including a ₹157.70 premium), totaling approximately ₹18.15 crore in principal and premium. Additionally, the company will pay a 4% annualized return for a seven-year period on these shares. The payout will be funded from the company's retained earnings as of March 31, 2026.
Confidence: HIGH
What changedThe company is executing a scheduled redemption of its preference share capital using its accumulated profits.
Why it mattersThis action reduces the company's future obligations toward preference shareholders but results in a significant one-time cash outflow relative to its annual PAT of ₹12 Cr.
Number of NCRPS to be redeemed: 10,82,387Redemption Price per share: ₹167.70Estimated Base Outflow: ₹18.15 CrOutflow vs Net Worth: ~7.4%Annualized Return Rate: 4%Record Date: July 21, 2026
📅 Short termThe stock may see neutral to slightly cautious movement as the market accounts for the cash outflow from retained earnings.
📈 Long termClearing preference share obligations simplifies the capital structure and removes the 4% annual return burden, which is structurally positive for equity shareholders.
⚠ Risk flags
- Significant cash outflow relative to TTM PAT of ₹12 Cr
- Potential impact on liquidity for ongoing ₹85 Cr organic expansion
Key Highlights
Redemption of 10,82,387 fully paid-up Non-Convertible Redeemable Preference Shares (NCRPS).
Redemption price set at ₹167.70 per share, comprising ₹10 face value and ₹157.70 premium.
Includes an annualized return of 4% for a period of 7 years on the redemption price.
Total base redemption value (excluding the 4% return) is approximately ₹18.15 Cr, which is ~7.4% of the company's Net Worth.
Record date for payment is July 21, 2026, with the payment date fixed for August 5, 2026.
👀 What to Watch
Investors should monitor the cash flow statement in the next quarterly report to see the impact of this ~₹20 Cr+ outflow on the company's liquidity, especially given the ongoing ₹85 Cr capex plan.
Aarti Surfactants Recommends Re. 1 Dividend and Approves FY26 Audited Financial Results
Aarti Surfactants has announced its audited standalone and consolidated financial results for the fiscal year ended March 31, 2026. The Board recommended a dividend of Re. 1 per equity share (10% of face value), subject to shareholder approval at the upcoming AGM. The company received an unmodified audit opinion, indicating no major accounting discrepancies. Additionally, the Board approved the re-appointment of cost and internal auditors for FY 2026-27 and reconstituted its Finance and Investment Committee.
Key Highlights
Recommended a dividend of Re. 1 per equity share (10% of face value) for FY 2025-26.
Approved audited standalone and consolidated financial results for the quarter and year ended March 31, 2026.
Auditors Gokhale & Sathe issued an unmodified opinion on the annual financial statements.
Re-appointed PHS & Associates as Cost Auditor and Raman S. Shah & Co. as Internal Auditor for FY 2026-27.
Reconstituted the Finance and Investment Committee to include Mr. Parimal H. Desai as a member.
👀 What to Watch
Investors should take note of the dividend recommendation and the clean audit report as indicators of stable governance. Review the detailed financial statements for year-on-year growth metrics once the full report is analyzed.
Aarti Surfactants Recommends ₹1 Final Dividend for FY 2025-26
Aarti Surfactants Limited has recommended a final dividend of ₹1 per equity share (10% of face value) for the financial year ended March 31, 2026. The board approved the audited standalone and consolidated financial results for the full year, which received an unmodified audit opinion from Gokhale & Sathe. Additionally, the company re-appointed its cost and internal auditors for the 2026-27 fiscal year. The dividend remains subject to shareholder approval at the upcoming Annual General Meeting.
Key Highlights
Recommended a final dividend of ₹1 per equity share of face value ₹10 (10% payout) for FY 2025-26
Approved audited standalone and consolidated financial results for the quarter and year ended March 31, 2026
Statutory auditors issued an unmodified opinion on the financial statements, confirming data reliability
Re-appointed PHS & Associates as Cost Auditor and Raman S. Shah & Co. as Internal Auditor for FY 2026-27
Re-constituted the Finance and Investment Committee with the inclusion of Mr. Parimal H. Desai
👀 What to Watch
Investors should monitor the announcement of the record date for the ₹1 dividend and review the detailed audited results for growth in the surfactants segment. The clean audit report is a positive sign regarding the company's financial transparency.
Aarti Surfactants Approves FY26 Results, Recommends Re. 1 Dividend per Share
Aarti Surfactants Limited has approved its audited financial results for the fiscal year ending March 31, 2026. The Board has recommended a dividend of Re. 1 per equity share, which is 10% of the face value of Rs. 10, subject to shareholder approval. Key administrative updates include the re-appointment of internal and cost auditors for FY 2026-27. Additionally, the Finance and Investment Committee has been reconstituted to include Mr. Parimal H. Desai as a member.
Key Highlights
Recommended a dividend of Re. 1 per equity share (10% of face value) for FY 2025-26.
Approved audited standalone and consolidated financial results for the quarter and year ended March 31, 2026.
Auditors issued an unmodified opinion on the financial statements, indicating no major accounting discrepancies.
Re-appointed Raman S. Shah & Co. as Internal Auditors and PHS & Associates as Cost Auditors for FY 2026-27.
Reconstituted the Finance and Investment Committee with the inclusion of Mr. Parimal H. Desai.
👀 What to Watch
Investors should view the dividend recommendation as a sign of stable operations; however, they should analyze the detailed profit and loss statements for margin trends. Monitor the impact of the reconstituted investment committee on future capital allocation strategies.
Aarti Surfactants Q3 Net Profit Surges 358% YoY to ₹3.66 Cr; Revenue Up 28%
Aarti Surfactants reported a robust performance for Q3 FY26, with consolidated revenue growing 27.6% YoY to ₹207.79 crore. The company's net profit witnessed a massive jump of 358% YoY, reaching ₹3.66 crore compared to ₹0.80 crore in the same period last year. Sequentially, net profit more than doubled from ₹1.56 crore in Q2 FY26, indicating strong operational momentum. Additionally, Valiant Organics Limited has withdrawn its application for re-classification to the 'Public' category, choosing to remain part of the 'Promoter Group'.
Key Highlights
Consolidated Revenue from Operations increased 27.6% YoY to ₹20,778.73 Lakhs.
Consolidated Net Profit grew by 358% YoY to ₹365.67 Lakhs from ₹79.75 Lakhs.
Profit Before Tax (PBT) for the quarter stood at ₹510.09 Lakhs, up from ₹120.75 Lakhs YoY.
9M FY26 consolidated revenue reached ₹60,285.26 Lakhs compared to ₹45,703.13 Lakhs in 9M FY25.
Valiant Organics Limited withdrew its request to be re-classified as a public shareholder, maintaining promoter group status.
👀 What to Watch
Investors should take note of the significant bottom-line recovery and margin expansion shown this quarter. The decision by Valiant Organics to remain in the promoter group provides stability to the shareholding structure.
Aarti Surfactants Q3 Net Profit Surges 358% YoY to ₹3.66 Cr; Revenue Up 28%
Aarti Surfactants reported a strong performance for the quarter ended December 31, 2025, with consolidated revenue growing 27.6% YoY to ₹207.79 crore. Net profit witnessed a massive jump of 358% YoY, reaching ₹3.66 crore compared to ₹0.80 crore in the same period last year. On a sequential basis, revenue and profit also showed robust growth of 16% and 135% respectively. Additionally, the company announced that Valiant Organics Limited has withdrawn its request for re-classification to the public category, choosing to remain in the promoter group.
Key Highlights
Consolidated Revenue from Operations rose 27.6% YoY to ₹20,778.73 Lakhs
Net Profit after tax surged 358% YoY to ₹365.67 Lakhs from ₹79.75 Lakhs in the year-ago quarter
Quarterly Basic EPS improved significantly to ₹4.32 from ₹0.95 YoY
Nine-month (9M FY26) Net Profit stands at ₹815.66 Lakhs, a 69% increase over 9M FY25
Valiant Organics Limited withdrew its application for re-classification from Promoter to Public category
👀 What to Watch
The company has demonstrated strong operational recovery and significant profit margin expansion this quarter. Investors should monitor the sustainability of this growth and the impact of the stable promoter structure on long-term governance.
Aarti Surfactants Credit Rating Downgraded to CARE BBB+ on Subdued H1 FY26 Margins
CARE Ratings has downgraded Aarti Surfactants Limited's long-term bank facilities worth ₹208.87 crores from CARE A- to CARE BBB+. Additionally, the rating for its ₹18.50 crore redeemable preference shares was lowered from CARE BBB+ to CARE BBB. The downgrade is primarily attributed to subdued profit margins reported during the first half of FY26. Despite a representation from the company to reconsider, the rating agency maintained the lower ratings, signaling concerns over operational efficiency.
Key Highlights
Long-term bank facilities of ₹208.87 crores downgraded from CARE A- to CARE BBB+ with Stable outlook
Redeemable preference shares worth ₹18.50 crores downgraded from CARE BBB+ to CARE BBB
Downgrade triggered by subdued operating margins observed in H1 FY26 performance
CARE Ratings rejected the company's representation to upgrade or maintain the previous rating
The 'Stable' outlook suggests the agency expects the company's credit profile to remain steady at these lower levels
👀 What to Watch
Investors should exercise caution as the downgrade may lead to higher borrowing costs and reflects underlying margin pressure. Monitor the next two quarters closely for signs of operational turnaround or further margin erosion.
